Significant progress in uncovering many of the molecular events with respect to control of bone formation has added considerably to our understanding of matrix mineralization. It is well established that insoluble collagen accumulation and cross-linking are essential for the development of a functional mineralized extracellular matrix. What is not known is how bone collagen maturation is regulated during development and whether cytokines modulate this process via the same mechanisms. Procollagen C-proteinase and lysyl oxidase have been identified as key players in the extracellular post-translational modification of collagen. In addition to processing procollagen, procollagen C-proteinase cleaves pro-lysyl oxidase into the 32 kDa active enzyme and the 18 kDa propeptide. Lysyl oxidase catalyzes the essential step necessary for collagen cross-linking. Recently, our laboratory has discovered a biological role for the 18 kDa propeptide in matrix mineralization.
In Aim 1, the role of regulation of procollagen C-proteinase and lysyl oxidase in the formation of a mineralized extracellular matrix will be investigated in developing fetal rat calvaria osteoblastic cultures. Analyses will include a variety of molecular parameters including mRNA levels, protein levels, and enzyme activity, as well as assessment of extracellular matrix formation by measuring insoluble collagen and inorganic calcium accumulation. The recent development of knockout mice that lack the BPM-1 gene that encodes procollagen C-proteinase provides a supplementary approach to establish the role of procollagen C- proteinase and lysyl oxidase processing on in vitro bone formation.
In Aim 2, the cytokine effects of TGF-beta and TNF-alpha on procollagen C- proteinase and lysyl oxidase, collagen synthesis, and collagen accumulation will be determined in developing osteoblastic cultures.
In Aim 3, the osteogenic activity of the 18 kDa propeptide will be characterized. For this purpose recombinant lysyl oxidase propeptide will be prepared in a eukaryotic expression system and used to carry out functional studies and to explore receptor mediated mechanisms. The results obtained from these studies will add significantly to the understanding of how extracellular events lead to matrix maturation and mineralization. Once the molecular parameters addressed in this proposal are clearly defined, it may be possible to exploit the information gained for the development of therapeutic approaches in a variety of diseases affecting bone integrity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE012209-03
Application #
6350588
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Zhang, Guo He
Project Start
1999-02-01
Project End
2003-01-31
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
3
Fiscal Year
2001
Total Cost
$209,639
Indirect Cost
Name
Boston University
Department
Dentistry
Type
Schools of Dentistry
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Guo, Ying; Pischon, Nicole; Palamakumbura, Amitha H et al. (2007) Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells. Am J Physiol Cell Physiol 292:C2095-102
Santana, Ronaldo B; Trackman, Philip C (2006) Controlled release of fibroblast growth factor 2 stimulates bone healing in an animal model of diabetes mellitus. Int J Oral Maxillofac Implants 21:711-8
Trackman, Philip C (2005) Diverse biological functions of extracellular collagen processing enzymes. J Cell Biochem 96:927-37
Pischon, Nicole; Babakhanlou-Chase, Hermik; Darbois, Laurent et al. (2005) A procollagen C-proteinase inhibitor diminishes collagen and lysyl oxidase processing but not collagen cross-linking in osteoblastic cultures. J Cell Physiol 203:111-7
Palamakumbura, Amitha H; Jeay, Sebastien; Guo, Ying et al. (2004) The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J Biol Chem 279:40593-600
Pischon, Nicole; Darbois, Laurent M; Palamakumbura, Amitha H et al. (2004) Regulation of collagen deposition and lysyl oxidase by tumor necrosis factor-alpha in osteoblasts. J Biol Chem 279:30060-5
Hong, Hsiang-Hsi; Pischon, Nicole; Santana, Ronaldo B et al. (2004) A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures. J Cell Physiol 200:53-62
Harlow, Christopher R; Rae, Mick; Davidson, Lindsay et al. (2003) Lysyl oxidase gene expression and enzyme activity in the rat ovary: regulation by follicle-stimulating hormone, androgen, and transforming growth factor-beta superfamily members in vitro. Endocrinology 144:154-62
Santana, Ronaldo B; Xu, Lei; Chase, Hermik Babakhanlou et al. (2003) A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 52:1502-10
Palamakumbura, Amitha H; Sommer, Pascal; Trackman, Philip C (2003) Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts. J Biol Chem 278:30781-7

Showing the most recent 10 out of 15 publications